Hip Arthroplasty
46
3
5
30
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.5%
3 terminated out of 46 trials
90.9%
+4.4% vs benchmark
15%
7 trials in Phase 3/4
20%
6 of 30 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 30 completed trials
Clinical Trials (46)
Hospital for Special Surgery Hip Arthroplasty Cohort
FAB Block vs. Placebo for Hip Arthroplasty Patients
DIPB vs. SIFIB for Postoperative Analgesia After Hip Surgery
Comparison of Pericapsular Nerve Group+ Lateral Femoral Cutaneous Nerve Block Versus Lumbar Erector Spinae Plane Block in Hip Arthroplasty Surgery
Sacral ESPB vs. PENG Block for Hip Hemiarthroplasty Analgesia
Orthopedic Procedures and Postoperative Delirium in Older Adults in the Czech Republic
Osseointegration of THA Grafted by PolyNASS (ACTISURF-CERAFIT® ) Versus Non-grafted THA (CERAFIT®)
Efficacy of Proprioceptive Neuromuscular Facilitation Exercise Program in Total Hip Arthroplasty
SFIB vs PENG Block in the Anesthesia for Total Hip Replacement
OPPOSED (anteriOr hiP arthroPlasty regiOnal aneSthEsia stuDy) Study
VR Simulation and Basic Skills in THA
Tactile Incentiviser Improves Partial Weight Bearing After Lower-Limb Surgery
Backwards Walking Programme Following Hip and Knee Arthroplasty
Effectiveness of Dual Task Training in Total Hip Arthroplasty
Stem Cells Predicting Orthopedic Outcomes
Rehabilitation to Patients Over 65 Years Undergoing THA
CMP vs Fascia Iliaca Block
Collared Versus Collarless Femoral Implants for Total Hip Arthroplasty
Routine Surgical Procedures During COVID-19 Pandemic: a French Nationwide Cohort Study
Optimizing Local Anesthetic Concentration for Continuous Lumbar Plexus Nerve Blocks